|
CV Information
 PROFESOR DR. ROSLINE BINTI HASSAN
| |
|---|---|
|
Grant's Name,"Project's Title" (Research Period)(Role)[Sponsorship]
| |
| 1 | MINISTRY OF SCIENCE, TECHNOLOGY AND INNOVATION (MOSTI), "SARS-COV-2 GENOMICS SURVEILLANCE" (01.11.2021 - 31.12.2022) (Principal) [ KEMENTERIAN SAINS, TEKNOLOGI & INOVASI (MOSTI) ] - Source: eR&I |
| 2 | EXTERNAL AGENCY (INDUSTRY/PRIVATE), "FAMILIAL CANCERS IN HOSPITAL USM : FUTURE DIRECTION OF INTERNAL DATABASE DEVELOPMENT FOR BIOBANKING" (24.02.2020 - 23.02.2021) (Principal) [ NEWCASTLE UNIVERSITY MEDICINE MALAYSIA (NUMED) ] - Source: eR&I |
| 3 | FUNDAMENTAL RESEARCH GRANT SCHEME (FRGS), "THE IMMUNOREGULATION OF HIGH DOSE VITAMIN C AND LOW DOSE CHEMOTHERAPY (HICLOCHEMO) AS A NOVEL CANCER CHEMOIMMUNOTHERAPEUTIC IN BREAST CANCER RATS MODEL" (01.09.2019 - 31.08.2022) (Principal) [ KEMENTERIAN PENDIDIKAN MALAYSIA ] - Source: eR&I |
| 4 | TRANSDICIPLINARY RESEARCH GRANT SCHEME (TRGS), "IMPACT ON ENVIRONMENTAL ASSETS : ELUCIDATING THE NUTRITIONAL AND IMMUNOLOGICAL FACTORS AS THE CONTRIBUTING TO HEALTH STATUS AMONG FLOOD VICTIM IN KELANTAN" (01.04.2015 - 31.12.2015) (Team Member) [ KEMENTERIAN PENGAJIAN TINGGI ] - Source: eR&I |
| 5 | TRANSDICIPLINARY RESEARCH GRANT SCHEME (TRGS), "HEALTH AND SAFETY: ASSESSING HEALTH IMPACTS OF FLOOD DISASTER IN KELANTAN TOWARD DEVELOPING EFFECTIVE PREPAREDNESS & RESPONSE PROGRAMMES" (01.04.2015 - 31.12.2015) (Head Program) [ KEMENTERIAN PENGAJIAN TINGGI ] - Source: eR&I |
| 6 | FUNDAMENTAL RESEARCH GRANT SCHEME (FRGS), "UNDERSTANDING THE INEFFECTIVE ERYTHROPOIESIS IN TRANSFUSION DEPENDENT THALASSAEMIA; ROLE OF AHSP AND TELOMERE LENGTH AS CONTRIBUTION FACTORS" (01.12.2014 - 30.11.2016) (Principal) [ KEMENTERIAN PENGAJIAN TINGGI ] - Source: eR&I |
| 7 | FUNDAMENTAL RESEARCH GRANT SCHEME (FRGS), "ISOLATION, CHARACTERIZATION AND DIFFERENTIATION, POTENTIAL OF MESENCHYMAL STEM CELL FROM WHOLE HUMAN PLACENTA" (15.10.2007 - 15.10.2009) (Principal) [ KEMENTERIAN PENGAJIAN TINGGI ] - Source: eR&I |
| 8 | SCIENCEFUND, "A STUDY TO INVESTIGATE THE EFFECT OF HORMONE REPLACEMENT THERAPY AND COMMERCIALLY AVAILABLE VITAMIN E ON PLATELET ACTIVATION MARKERS AS DETERMINED BY FLOW CYTOMETERY IN POST-MENOPAUSAL WOMEN" (01.07.2007 - 30.06.2009) (Principal) [ KEMENTERIAN SAINS, TEKNOLOGI & INOVASI (MOSTI) ] - Source: eR&I |
| 9 | , "MICRORNAS IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML) IN RESPONSE TO IMATINIB TREATMENT FOR QUANTITATIVE EXPRESSION PROFILING" (01.01.1900 - 01.01.1900) (06) [ MOH ] - Source: HCMSv3 |